CMMB

Chemomab Therapeutics Ltd.CIK 1534248 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

$13.0K

4 trades · 1 insiders

Net · 90d

$-13.0K

Insiders on file

AI insights for CMMB PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CMMB

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Cohen Neil Harris	Director	41	$147.4K	$17.9K	2026-08-28
Mor George Adi	Chief Scientific Officer	12	$20.2K	$1.28M	2026-05-29
Quigley Jill M.	Director	2	$0	$0	2023-06-16
Fatal Sigal	Chief Financial Officer	4	$0	$0	2023-06-14
Darvish Nissim	Director	16	$5.1K	$0	2023-06-14
Moses Alan Charles	Director	6	$0	$0	2023-03-16
Nicaise Claude	Director	6	$0	$0	2023-03-16
OrbiMed Israel BioFund GP Limited Partnership	10% Owner	2	$0	$1.21M	2023-01-03
Maryles Joel Michael	Director	11	$5.6K	$0	2022-05-24
Marvin Donald	Executive VP, CFO & COO	9	$6.7K	$0	2022-03-16
Pfost Dale R	Chief Executive Officer	3	$9.9K	$0	2022-03-14
SQUINTO STEPHEN P	Director	1	$0	$0	2021-04-19
OrbiMed Israel GP Ltd.	10% Owner	2	$0	$0	2021-03-16
THIEL PETER	10% Owner	2	$0	$0	2021-03-16

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Cohen Neil Harris	Director	S Sale	2026-08-28	2026-09-01	1,000	$2.80	$2.8K	33,000	SEC↗
Cohen Neil Harris	Director	S Sale	2026-08-28	2026-09-01	1,000	$2.80	$2.8K	33,000	SEC↗
Cohen Neil Harris	Director	S Sale	2026-08-27	2026-09-01	1,304	$2.85	$3.7K	34,000	SEC↗
Cohen Neil Harris	Director	S Sale	2026-08-27	2026-09-01	1,304	$2.85	$3.7K	34,000	SEC↗
Mor George Adi	Chief Executive Officer	J Other	2026-05-29	2026-06-01	18,750	—	$0	18,750	SEC↗
Mor George Adi	Chief Executive Officer	J Other	2026-05-29	2026-06-01	31,712	—	$0	31,712	SEC↗
Mor George Adi	Chief Executive Officer	P Buy	2026-05-29	2026-06-01	4,926	$2.08	$10.2K	139,131	SEC↗
Mor George Adi	Chief Executive Officer	P Buy	2026-05-29	2026-06-01	4,878	$2.05	$10.0K	134,205	SEC↗
Cohen Neil Harris	Director	A Award deriv	2026-03-16	2026-09-01	5,172	—	$0	18,075	SEC↗
Cohen Neil Harris	Director	A Award deriv	2026-03-16	2026-09-01	5,172	—	$0	18,075	SEC↗
Cohen Neil Harris	Director	A Award deriv	2025-03-16	2026-09-01	3,821	—	$0	12,903	SEC↗
Cohen Neil Harris	Director	A Award deriv	2025-03-16	2026-09-01	3,821	—	$0	12,903	SEC↗
Cohen Neil Harris	Director	A Award deriv	2024-03-18	2026-09-01	2,520	—	$0	9,082	SEC↗
Cohen Neil Harris	Director	A Award deriv	2024-03-18	2026-09-01	2,520	—	$0	9,082	SEC↗
Quigley Jill M.	Director	A Award deriv	2023-06-16	2023-06-20	6,857	—	$0	20,497	SEC↗
Darvish Nissim	Director	A Award deriv	2023-06-14	2023-07-05	20,572	—	$0	20,572	SEC↗
Fatal Sigal	Chief Financial Officer	A Award deriv	2023-06-14	2023-06-16	102,860	—	$0	167,860	SEC↗
Cohen Neil Harris	Director	A Award deriv	2023-03-21	2026-09-01	1,714	—	$0	6,562	SEC↗
Cohen Neil Harris	Director	A Award deriv	2023-03-21	2026-09-01	1,714	—	$0	6,562	SEC↗
Darvish Nissim	Director	A Award deriv	2023-03-16	2023-07-05	6,857	—	$0	6,857	SEC↗
Darvish Nissim	Director	A Award deriv	2023-03-16	2023-03-23	6,857	—	$0	6,857	SEC↗
Cohen Neil Harris	Director	A Award deriv	2023-03-16	2023-03-23	6,875	—	$0	6,875	SEC↗
Nicaise Claude	Director	A Award deriv	2023-03-16	2023-03-23	6,857	—	$0	6,857	SEC↗
Nicaise Claude	Director	A Award deriv	2023-03-16	2023-03-23	6,820	—	$0	6,820	SEC↗
Nicaise Claude	Director	A Award deriv	2023-03-16	2023-03-23	11,884	—	$0	11,884	SEC↗
Moses Alan Charles	Director	A Award deriv	2023-03-16	2023-03-23	6,857	—	$0	6,857	SEC↗
Mor George Adi	Chief Scientific Officer	S Sale	2023-01-03	2023-01-05	7,700	$5.03	$38.7K	317,075	SEC↗
Mor George Adi	Chief Scientific Officer	S Sale	2023-01-03	2023-01-05	6,100	$5.03	$30.7K	251,147	SEC↗
OrbiMed Israel BioFund GP Limi	10% Owner	S Sale	2023-01-03	2023-01-05	266,376	$3.34	$889.7K	2,311,798	SEC↗
OrbiMed Israel BioFund GP Limi	10% Owner	S Sale	2023-01-03	2023-01-05	70,524	$4.51	$318.1K	2,241,274	SEC↗
Mor George Adi	Chief Scientific Officer	S Sale	2022-11-16	2022-11-17	257,248	$2.08	$535.1K	257,247	SEC↗
Mor George Adi	Chief Scientific Officer	S Sale	2022-11-16	2022-11-17	324,775	$2.08	$675.5K	324,775	SEC↗
Cohen Neil Harris	Director	S Sale	2022-11-16	2022-11-18	2,409	$2.00	$4.8K	10,000	SEC↗
Fatal Sigal	Chief Financial Officer	A Award deriv	2022-11-08	2023-06-16	29,400	—	$0	65,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2022-06-16	2023-06-20	13,640	—	$0	13,640	SEC↗
Maryles Joel Michael	Director	P Buy	2022-05-24	2022-05-25	33	$2.76	$91	1,433	SEC↗
Maryles Joel Michael	Director	P Buy	2022-05-24	2022-05-25	400	$2.89	$1.2K	1,400	SEC↗
Cohen Neil Harris	Director	P Buy	2022-05-18	2022-05-19	2,000	$3.19	$6.4K	12,409	SEC↗
Maryles Joel Michael	Director	P Buy	2022-03-18	2022-03-21	500	$4.32	$2.2K	500	SEC↗
Maryles Joel Michael	Director	P Buy	2022-03-18	2022-03-21	500	$4.36	$2.2K	1,000	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-16	2022-06-21	250	$3.25	$813	2,000	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-16	2022-06-21	250	$3.30	$825	1,750	SEC↗
Cohen Neil Harris	Director	P Buy	2022-03-14	2022-03-15	2,000	$4.20	$8.4K	6,409	SEC↗
Cohen Neil Harris	Director	P Buy	2022-03-14	2022-03-15	2,000	$4.30	$8.6K	8,409	SEC↗
Cohen Neil Harris	Director	P Buy	2022-03-14	2022-03-15	2,000	$4.56	$9.1K	10,409	SEC↗
Pfost Dale R	Chief Executive Officer	P Buy	2022-03-14	2022-03-15	1,800	$3.98	$7.2K	1,800	SEC↗
Pfost Dale R	Chief Executive Officer	P Buy	2022-03-14	2022-03-15	700	$3.97	$2.8K	2,500	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-14	2022-03-21	250	$3.98	$995	500	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-14	2022-03-21	250	$4.00	$1.0K	250	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-14	2022-03-21	250	$4.20	$1.1K	1,500	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-14	2022-03-21	250	$4.10	$1.0K	1,250	SEC↗
Marvin Donald	Executive VP, CFO & COO	P Buy	2022-03-14	2022-03-21	250	$3.90	$975	1,000	SEC↗
Darvish Nissim	Director	P Buy	2022-03-11	2022-03-14	1,200	$4.28	$5.1K	1,200	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2026-09-01	1,705	—	$0	4,848	SEC↗
Darvish Nissim	Director	A Award deriv	2022-03-07	2023-07-05	6,820	—	$0	6,820	SEC↗
Darvish Nissim	Director	A Award deriv	2022-03-07	2023-03-23	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2023-03-23	6,820	—	$0	6,820	SEC↗
Moses Alan Charles	Director	A Award deriv	2022-03-07	2023-03-23	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2022-11-18	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2022-05-19	6,820	—	$0	6,820	SEC↗
Maryles Joel Michael	Director	A Award deriv	2022-03-07	2022-05-25	6,820	—	$0	6,820	SEC↗
Maryles Joel Michael	Director	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
Moses Alan Charles	Director	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
Nicaise Claude	Director	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
Darvish Nissim	Director	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
Darvish Nissim	Director	A Award deriv	2022-03-07	2022-03-14	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2022-03-15	6,820	—	$0	6,820	SEC↗
Maryles Joel Michael	Director	A Award deriv	2022-03-07	2022-03-21	6,820	—	$0	6,820	SEC↗
Cohen Neil Harris	Director	A Award deriv	2022-03-07	2026-09-01	1,705	—	$0	4,848	SEC↗
Cohen Neil Harris	Director	P Buy	2021-12-06	2021-12-08	2,000	$7.43	$14.9K	4,409	SEC↗
Fatal Sigal	Chief Financial Officer	A Award deriv	2021-11-11	2023-06-16	35,600	—	$0	35,600	SEC↗
Marvin Donald	Executive VP, CFO & COO	A Award deriv	2021-11-08	2022-06-21	196,875	—	$0	196,875	SEC↗
Marvin Donald	Executive VP, CFO & COO	A Award deriv	2021-11-08	2022-03-21	196,875	—	$0	196,875	SEC↗
Pfost Dale R	Chief Executive Officer	A Award deriv	2021-10-25	2022-03-15	459,353	—	$0	459,353	SEC↗
Fatal Sigal	Chief Financial Officer	A Award deriv	2021-05-07	2021-05-10	35,653	—	$0	35,653	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2026-09-01	2,971	—	$0	3,143	SEC↗
Darvish Nissim	Director	A Award deriv	2021-04-19	2023-07-05	11,884	—	$0	11,884	SEC↗
Darvish Nissim	Director	A Award deriv	2021-04-19	2023-03-23	11,884	—	$0	11,884	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2023-03-23	11,884	—	$0	11,884	SEC↗
Moses Alan Charles	Director	A Award deriv	2021-04-19	2023-03-23	11,884	—	$0	11,884	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2022-11-18	11,884	—	$0	11,884	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2022-05-19	11,884	—	$0	11,884	SEC↗
Maryles Joel Michael	Director	A Award deriv	2021-04-19	2022-05-25	11,884	—	$0	11,884	SEC↗
Maryles Joel Michael	Director	A Award deriv	2021-04-19	2022-03-09	11,884	—	$0	11,884	SEC↗
Moses Alan Charles	Director	A Award deriv	2021-04-19	2022-03-09	11,884	—	$0	11,884	SEC↗
Nicaise Claude	Director	A Award deriv	2021-04-19	2022-03-09	11,884	—	$0	11,884	SEC↗
Darvish Nissim	Director	A Award deriv	2021-04-19	2022-03-09	11,884	—	$0	11,884	SEC↗
Darvish Nissim	Director	A Award deriv	2021-04-19	2022-03-14	11,884	—	$0	11,884	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2022-03-15	11,884	—	$0	11,884	SEC↗
Maryles Joel Michael	Director	A Award deriv	2021-04-19	2022-03-21	11,884	—	$0	11,884	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
Darvish Nissim	Director	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
Maryles Joel Michael	Director	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
Moses Alan Charles	Director	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
Nicaise Claude	Director	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
SQUINTO STEPHEN P	Director	A Award deriv	2021-04-19	2021-04-21	23,768	—	$0	23,768	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-04-19	2026-09-01	2,971	—	$0	3,143	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-03-16	2023-03-23	688	—	$0	688	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-03-16	2022-11-18	688	—	$0	688	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-03-16	2022-05-19	688	—	$0	688	SEC↗
Darvish Nissim	Director	A Award deriv	2021-03-16	2022-03-14	10,123	—	$0	10,123	SEC↗
Cohen Neil Harris	Director	A Award deriv	2021-03-16	2022-03-15	688	—	$0	688	SEC↗
THIEL PETER	10% Owner	P Buy deriv	2021-03-16	2021-03-18	23,054	—	$0	23,054	SEC↗
OrbiMed Israel GP Ltd.	10% Owner	A Award deriv	2021-03-16	2021-03-18	28,817	—	$0	28,817	SEC↗
Cohen Neil Harris	Director	P Buy deriv	2021-03-16	2021-03-26	688	—	$0	688	SEC↗
THIEL PETER	10% Owner	P Buy	2021-03-16	2021-03-18	230,536	—	$0	1,108,509	SEC↗
OrbiMed Israel GP Ltd.	10% Owner	A Award	2021-03-16	2021-03-18	288,170	$17.35	$5.00M	2,578,174	SEC↗
Cohen Neil Harris	Director	P Buy	2021-03-16	2021-03-26	2,409	$41.51	$100.0K	2,409	SEC↗
Cohen Neil Harris	Director	A Award deriv	2020-07-16	2026-09-01	172	—	$0	172	SEC↗
Cohen Neil Harris	Director	A Award deriv	2020-07-16	2026-09-01	172	—	$0	172	SEC↗
Mor George Adi	Chief Scientific Officer	A Award deriv	2018-03-15	2023-01-05	131,698	—	$0	131,698	SEC↗
Mor George Adi	Chief Scientific Officer	A Award deriv	2018-03-15	2022-11-17	131,698	—	$0	131,698	SEC↗
Darvish Nissim	Director	A Award deriv	2016-10-28	2023-07-05	10,123	—	$0	10,123	SEC↗
Mor George Adi	Chief Scientific Officer	A Award deriv	2016-10-28	2023-01-05	33,725	—	$0	33,725	SEC↗
Darvish Nissim	Director	A Award deriv	2016-10-28	2023-03-23	10,123	—	$0	10,123	SEC↗
Mor George Adi	Chief Scientific Officer	A Award deriv	2016-10-28	2022-11-17	33,725	—	$0	33,725	SEC↗